TRAD Tests & Radiations

About TRAD Tests & Radiations

A Other / Uncategorized player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• PR Newswire · 2026-10-19
  Trad Tests Radiations announces Phase II readout for lead theranostic candidate
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Nuclear Medicine Today · 2026-05-08
  Trad Tests Radiations expands cyclotron capacity to meet Lu-177 demand
  The work builds on more than a decade of radiochemistry collaboration.
• STAT News · 2026-04-05
  Trad Tests Radiations signs supply agreement to support late-stage trials
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• Imaging Wire · 2026-03-10
  Trad Tests Radiations appoints new Chief Medical Officer ahead of pivotal trial
  Coverage notes the company's growing footprint in the radioligand therapy space.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.